Imunon, Inc.
CLSN
Rangering i aksjer
#34951
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Aksjekurs
$1.96
Sist synkronisert: 2022-09-20
Markedsverdi
$4.46M
Endring (1 dag)
0.00%
Endring (1 år)
122.70%
Land
US
Handel Imunon, Inc. (CLSN)
Kategori
Healthcare
Historikk for aksjesplitt for Imunon, Inc. (CLSN)
Aksjen Imunon, Inc. (symbol: CLSN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én CLSN-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 CLSN-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én CLSN-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 CLSN-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
